文献速递妇产影像US

现代基因组技术时代晚期羊膜穿刺术的作用

Role of late amniocentesis in the era of modern genomic technologies.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-04-12

该回顾性研究分析了2013年6月至2017年3月在哈达萨医学中心于孕24+0至38+6周行羊膜穿刺的291名孕妇(303例胎儿),所有病例均行染色体微阵列分析。最常见指征为超声异常(204/303,67%),术后1周和1个月内早产率分别为1.7%和5.1%,CMA使传统核型分析诊断产出翻倍,最大诊断产出17.5%见于两个及以上解剖系统超声异常胎儿。

要点

  • 晚期羊膜穿刺(孕24周后)最常见指征为超声异常,占67%(204/303例胎儿)。
  • CMA使非整倍体检出率3%基础上额外检出3%致病/可能致病拷贝数变异,诊断产出翻倍。
  • 两个及以上解剖系统超声异常胎儿诊断产出最高,达17.5%。

核心结论

  • 晚期羊膜穿刺中CMA较传统染色体分析提高胎儿异常检出率并缩短周转时间,可能有助于检出胎儿异常或安抚晚期出现超声异常的父母,但可能暴露意义不确定的发现,应预先咨询,操作似乎安全。

研究设计与样本

  • 回顾性分析2013年6月至2017年3月哈达萨医学中心孕24+0至38+6周行羊膜穿刺的291名孕妇(303例胎儿,277例单胎和14例双胎妊娠,其中两对双胎中一胎在羊膜穿刺前终止),所有羊膜穿刺均行CMA。

诊断标准与关键数值

  • 非整倍体检出9例(3%),致病/可能致病拷贝数变异9例(3%),提示CMA使传统核型分析诊断产出翻倍;两个及以上胎儿解剖系统超声异常亚组最大诊断产出17.5%;意义不确定变异或易感位点另见9例(3%)。

临床应用与阅片要点

  • 作者认为晚期羊膜穿刺可能作为检出胎儿异常或安抚晚期出现超声异常父母的有用工具,但CMA可能暴露意义不确定的发现,应预先咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Traditionally, amniocentesis is performed between 17 and 23 weeks of gestation. This enables decisions regarding the course of pregnancy to be made before viability. Less frequently, amniocentesis is performed in the third trimester. Advanced genomic technologies such as chromosomal microarray analysis (CMA) provide more detailed information about the fetus compared with traditional G-banded chromosomal analysis. The aim of this study was to assess the indications for and safety of late amniocentesis, genetic-test results (especially in the context of CMA technology) and outcome of pregnancies that underwent the procedure after 24 weeks.

METHODS: Medical records were analyzed retrospectively of all women in whom amniocentesis was performed at a gestational age of 24 + 0 to 38 + 6 weeks, at Hadassah Medical Center, between June 2013 and March 2017. Parameters investigated included indications for late amniocentesis, complications, CMA results and pregnancy outcome.

RESULTS: During the study period, 291 women (303 fetuses, 277 singleton and 14 twin pregnancies; in two twin pairs, one fetus was terminated before amniocentesis) underwent late amniocentesis. CMA was performed in all instances of amniocentesis. The most frequent indication was abnormal sonographic finding(s) (204/303 fetuses, 67%). Preterm delivery occurred in 1.7% and 5.1% of pregnancies within the first week and within 1 month following the procedure, respectively. Aneuploidy was detected in nine (3%) fetuses and nine (3%) others had a pathogenic/likely pathogenic copy number variant, suggesting that CMA doubled the diagnostic yield of traditional karyotyping. Maximal diagnostic yield (17.5%) was achieved for the subgroup of fetuses referred with abnormal sonographic findings in two or more fetal anatomical systems. Variants of uncertain significance or susceptibility loci were found in another nine (3%) fetuses.

CONCLUSIONS: In pregnancies undergoing late amniocentesis, CMA increased detection rates of fetal abnormalities and had a shorter turnaround time compared with traditional chromosomal analysis; therefore, late amniocentesis may serve as a helpful tool for detecting fetal abnormalities or reassuring parents following late-appearing abnormal sonographic findings. However, CMA may expose findings of uncertain significance, about which the couple should be precounseled. The procedure appears to be safe. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Daum H, Ben David A, Nadjari M, et al. Role of late amniocentesis in the era of modern genomic technologies. Ultrasound Obstet Gynecol. 2019. PMID: 30155922. doi:10.1002/uog.20113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。